Cardiorenal protection with SGLT2: Lessons from the cardiovascular outcome trials
{{output}}
Sodium glucose cotransporter 2 (SGLT2) inhibitors are a class of drugs that were primarily developed for the treatment of type 2 diabetes mellitus. However, these agents have shown to provide additional beneficial effects. We will discuss three main topics reg... ...